OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
20
Results
Show all
Save search
Copy query
Show results for
Unknown
(19)
Proteomics
(1)
Repository
MassIVE
(1)
Instrument Platform
Q Exactive
(1)
Publication Date
2016
(1)
Release Date
2021
(6)
2023
(5)
2022
(4)
2020
(2)
2025
(1)
2016
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Impaired Bile Secretion Promotes Hepatobiliary Injury in Sickle Cell Disease.
Not available
S-EPMC7923682
|
biostudies-literature
Cite
Extracellular Matrix Analysis of Human Varicose Veins
To understand the consequences of venous hypertension, normal and varicose veins were evaluated using proteomics approaches targeting the extracellular matrix.
ORGANISM(S):
Homo Sapiens (ncbitaxon:9606)
2016-08-17
|
MSV000080062
|
MassIVE
Cite
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Not available
S-EPMC4985288
|
biostudies-literature
Cite
Effect of Convalescent Plasma on Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial.
Not available
S-EPMC8491132
|
biostudies-literature
Cite
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8084355
|
biostudies-literature
Cite
SARS-CoV-2 evolution during treatment of chronic infection.
Not available
S-EPMC7610568
|
biostudies-literature
Cite
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial.
Not available
S-EPMC8121538
|
biostudies-literature
Cite
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC7884931
|
biostudies-literature
Cite
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8830904
|
biostudies-literature
Cite
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8598213
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets